AMGEN Profit Margin

The latest profit margin for AMGN is 22.95% as of June 2026. That compares with 18.96% in the prior-year period — up 21.0% year over year. That is above the Healthcare sector average of 13.76%. Investors often review this figure alongside AMGEN's historical trend and sector peers before judging valuation or financial health.

Over the past year, AMGN's profit margin moved from 18.96% to 22.95% — a 21.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AMGEN's valuation or profitability profile.

Against Healthcare companies, AMGN currently prints 22.95% for profit margin, while the sector average sits near 13.76%. That is roughly 66.8% above the sector mean. Large gaps often invite a closer look at AMGEN's growth, margins, and balance sheet.

Profit Margin shows how effectively AMGEN converts resources into returns. At 22.95%, AMGN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 18.96% in the prior-year period — up 21.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AMGN's profit margin (22.95%), review year-over-year change from 18.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.